In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Control group : LAENNEC subcutaneous injection (4 ml) Experimental group : LAENNEC intravenous injection (10 ml)
Epistemonikos ID: 3e0bf5b2b0ca8971165bca765d34823f25b16034
First added on: Aug 01, 2024